CHLORHEXIDINE ALCOHOL FREE MOUTHWASH

देश: कनाडा

भाषा: अंग्रेज़ी

स्रोत: Health Canada

इसे खरीदें

सक्रिय संघटक:

CHLORHEXIDINE GLUCONATE

थमां उपलब्ध:

EURO-PHARM INTERNATIONAL CANADA INC

ए.टी.सी कोड:

A01AB03

INN (इंटरनेशनल नाम):

CHLORHEXIDINE

डोज़:

0.12%

फार्मास्यूटिकल फॉर्म:

MOUTHWASH

रचना:

CHLORHEXIDINE GLUCONATE 0.12%

प्रशासन का मार्ग:

BUCCAL

पैकेज में यूनिट:

500ML/4L

प्रिस्क्रिप्शन प्रकार:

Prescription

चिकित्सीय क्षेत्र:

MISCELLANEOUS ANTI-INFECTIVES

उत्पाद समीक्षा:

Active ingredient group (AIG) number: 0107629007; AHFS:

प्राधिकरण का दर्जा:

CANCELLED POST MARKET

प्राधिकरण की तारीख:

2021-06-03

उत्पाद विशेषताएं

                                1
PRODUCT MONOGRAPH
PR
CHLORHEXIDINE ALCOHOL FREE
Chlorhexidine Gluconate Oral Rinse, 0.12% w/v House Standard
ANTIGINGIVITIS ORAL RINSE
EURO-PHARM INTERNATIONAL CANADA INC.
9400 BOUL. LANGELIER
MONTREAL, QUEBEC
H1P 3H8
DATE OF PREPARATION:
JULY 6, 2017
CONTROL NO.: 205962
2
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................ 3
SUMMARY PRODUCT INFORMATION
.......................................................................
3
INDICATIONS AND CLINICAL USE
.............................................................................
3
CONTRAINDICATIONS
..................................................................................................
3
WARNINGS AND PRECAUTIONS
.................................................................................
4
ADVERSE REACTIONS
...................................................................................................
5
DRUG INTERACTIONS
...................................................................................................
5
DOSAGE AND ADMINISTRATION
...............................................................................
5
OVERDOSAGE
.................................................................................................................
6
ACTION AND CLINICAL PHARMACOLOGY
............................................................. 7
STORAGE AND STABILITY
...........................................................................................
8
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................. 8
PART II: SCIENTIFIC INFORMATION
................................................................................
9
PHARMACEUTICAL INFORMATION
...........................................................................
9
CLINICAL TRIALS
.........................................................................................................
10
TOXICOLOGY
...................................................................................
                                
                                पूरा दस्तावेज़ पढ़ें
                                
                            

अन्य भाषाओं में दस्तावेज़

उत्पाद विशेषताएं उत्पाद विशेषताएं फ़्रेंच 06-07-2017

इस उत्पाद से संबंधित अलर्ट देखें

दस्तावेज़ इतिहास देखें